Full Text View
Tabular View
Study Results
Related Studies
Pilot Study to Compare ISOVUE®-250 and VISIPAQUE™ 270 for Motion Artifact and Pain in Peripheral DSA
This study has been completed.
Study NCT00740207   Information provided by Bracco Diagnostics, Inc

First Received on August 20, 2008.   Last Updated on May 5, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Arterial Occlusive Diseases
Peripheral Arterial Disease
More general conditions related to this trial
Arteriosclerosis
Atherosclerosis
Cardiovascular Diseases
Peripheral Vascular Diseases
Vascular Diseases
Interventions listed in this trial
VISIPAQUE 270
Isovue 250
Sponsors listed in this trial
Bracco Diagnostics, Inc


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services